Steven Charlton Email

VP, Pharmacology . OMass

Current Roles

Employees:
94
Revenue:
$14.6M
About
OMass Therapeutics is a private pharmaceutical company, focused on structural mass spectrometry to discover novel medicines. The company uses its suite of proprietary technologies based on high-resolution mass spectrometry to study intact protein assemblies. The technology enables detection of drug leads that not only bind to the target complex, but also exert a functional effect through modulating complex formation. These methods are being applied to drug discovery for a variety of complex targets, including membrane receptors, addressing severe unmet medical needs. OMass is backed by Syncona Ltd and Oxford Sciences Innovation.
OMass Address
Chancellor Court, John Smith Drive
Oxford, null
OMass Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.